FDA approves Lupin's generic diabetes drug

07/22/2013 | Business Standard (India) · RTT News

The FDA has granted Lupin Pharmaceuticals approval for its metformin hydrochloride extended release tablets in 500 mg and 1000 mg strengths to boost glucose control in patients with type 2 diabetes. The drug is a generic version of Santarus' Glumetza HCl ER Tablets.

View Full Article in:

Business Standard (India) · RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA